H40.24 Residual stage of angle-closure glaucoma

Name of the Condition

• Residual Stage of Angle-Closure Glaucoma

Summary

Residual stage of angle-closure glaucoma refers to the phase following an acute or chronic angle-closure event where the drainage angle remains partially or fully closed, but intraocular pressure may be controlled or stable. This stage indicates persistent anatomical changes or scarring from prior angle closure, with a risk of ongoing optic nerve damage if not monitored. Vision loss may be irreversible, and regular follow-up is essential to prevent progression.

Causes

The residual stage typically results from prior angle-closure episodes, where anatomical changes (e.g., peripheral anterior synechiae, iris bombe) or scarring prevent full reopening of the drainage angle. Contributing factors include incomplete treatment of acute episodes, chronic angle narrowing, or delayed intervention leading to permanent structural alterations.

Risk Factors

• History of acute or chronic angle-closure glaucoma.
• Persistent anatomical narrowing of the drainage angle.
• Peripheral anterior synechiae (adhesions) from prior inflammation.
• Inadequate or delayed treatment of prior angle-closure events.
• Age-related lens thickening or other structural eye changes.

Symptoms

• Persistent or intermittent elevated intraocular pressure.
• Gradual or stable vision loss (often irreversible).
• Residual optic nerve damage visible on examination.
• Possible mild eye discomfort or blurred vision.
• No acute symptoms (e.g., pain, nausea) unless pressure spikes occur.

Diagnosis

Diagnosis requires a comprehensive eye exam, including tonometry to assess intraocular pressure, gonioscopy to evaluate drainage angle patency, and optic nerve assessment (e.g., OCT or fundoscopy) to detect residual damage. Visual field testing may reveal permanent peripheral vision loss. History of prior angle-closure events is critical for context.

Treatment Options

Treatment focuses on managing intraocular pressure and preventing further damage. Options may include topical or oral medications (e.g., beta-blockers, prostaglandin analogs), laser therapy (e.g., iridotomy or cyclophotocoagulation), or surgery (e.g., trabeculectomy). Regular monitoring adjusts therapy to maintain pressure control.

Prognosis and Follow-Up

Prognosis depends on the extent of optic nerve damage and adherence to treatment. Residual vision loss is often irreversible, but controlled intraocular pressure can slow progression. Follow-up includes regular pressure checks, optic nerve imaging, and visual field testing to detect changes early. Lifelong monitoring is typically recommended.

Complications

• Progressive optic nerve damage leading to permanent vision loss.
• Recurrent angle closure with acute pressure spikes.
• Secondary glaucoma from scarring or inflammation.
• Reduced quality of life due to vision impairment.

Lifestyle & Prevention

• Adhere to prescribed medications and follow-up schedules.
• Avoid medications that dilate pupils (e.g., certain cold or allergy drugs) without consulting an eye care provider.
• Protect eyes from injury to prevent triggering angle closure.
• Maintain overall eye health through regular exams, especially if risk factors exist.

When to Seek Professional Help

Seek immediate care for sudden eye pain, blurred vision, halos around lights, or nausea—signs of acute pressure elevation. For residual stage, contact an eye specialist if vision worsens, pressure feels uncontrolled, or new symptoms (e.g., redness, discharge) develop.

Tips for Medical Coders

Document the residual stage clearly, noting prior angle-closure history and current management. Specify if the condition is unilateral or bilateral, and include details on intraocular pressure control or optic nerve status. Ensure coding aligns with clinical documentation of anatomical changes (e.g., synechiae) or treatment response.